New study reveals physical activity in midlife and later life can reduce dementia risk by up to 45%, offering significant ...
A group of Cleveland-area women became friends while their husbands battled Alzheimer's. Long after all six men died, they ...
MedPage Today on MSN
Leading Drug Fails to Slow Alzheimer's Progression
High-sensitivity C-reactive protein (CRP) decreased significantly in the semaglutide group, with estimated treatment ratios ...
Luton Today on MSN
Local dementia group celebrates 10 years of supporting people in Bedfordshire and Luton
A group that supports people living with young-onset dementia is celebrating its tenth anniversary. The group, run by ...
A deep analysis of semaglutide’s phase 3 AD trials shows no cognitive or functional benefit despite biomarker gains, yet ...
LATE dementia, a progressive brain disorder affecting older adults, is increasingly being recognized as distinct from ...
MedPage Today on MSN
Year in Review: Alzheimer's Disease
News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers reported 3-year outcomes for both anti-amyloid drugs, lecanemab (Leqembi) and ...
Low choline levels in individuals with obesity may signal future brain issues, including Alzheimer's, a study in Aging and ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
For individuals diagnosed with Alzheimer’s disease or acting as the caretaker for someone with Alzheimer’s, support and ...
Spermine, a small but powerful molecule in the body, helps neutralize harmful protein accumulations linked to Alzheimer’s and ...
Delve into Vandria's technology and its Alzheimer's candidate, VNA-318, the first mitophagy-based candidate in Alzheimer's in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results